ChipCare’s handheld analyzer attracts one of Canada’s largest-ever healthcare angel investments
Device could significantly improve HIV diagnostics in developing world
OTTAWA, September 16, 2013 — An innovative, handheld point-of-care analyzer, developed by ChipCare Corporation, has secured one of the largest ever angel investments in Canada’s healthcare sector.
Phase II financing has closed, with an investment of $2.05M to support ChipCare’s continuing development and commercialization over the next three years.
Media coverage: Biotechnology Focus, TechVibes, BetaKit, Healthrender, Crunchbase, Toronto Star and VentureLab.
The financing evolved through a uniquely collaborative funding model among Canadian social angel investors, including Maple Leaf Angels, MaRS Innovation and the University of Toronto (Connaught Fund), with special financing leadership from Grand Challenges Canada and the Government of Canada.